124.8K XNAS Volume
XNAS 03 Apr, 2025 4:00 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Robert J. Markelewicz | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Nov 2024 | 24,300 | 24,300 | - | - | Stock option (right to buy) | |
| Robert J. Markelewicz | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Nov 2024 | 538,600 | 538,600 | - | - | Stock option (right to buy) | |
| Robert J. Markelewicz | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Nov 2024 | 29,800 | 29,800 | - | - | Stock option (right to buy) | |
| Robert J. Markelewicz | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Nov 2024 | 40,800 | 40,800 | - | - | Stock option (right to buy) | |
| Robert J. Markelewicz | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Nov 2024 | 41,700 | 41,700 | - | - | Stock option (right to buy) | |
| Robert J. Markelewicz | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Nov 2024 | 74,600 | 74,600 | - | - | Stock option (right to buy) | |
| Robert J. Markelewicz | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Nov 2024 | 10,200 | 10,200 | - | - | Stock option (right to buy) | |
| Jin Wook Miles Suk | Director, Co-CEO & Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Nov 2024 | 91,900 | 91,900 | - | 0 | Common Stock, par value $0.0001 per share | |
| Ian Chan | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Nov 2024 | 6,528,200 | 6,528,200 | - | 0 | Common Stock, par value $0.0001 per share | |
| Ian Chan | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Nov 2024 | 1,137,200 | 1,137,200 | - | 0 | Common Stock, par value $0.0001 per share | |
| Ian Chan | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Nov 2024 | 987,400 | 987,400 | - | 0 | Common Stock, par value $0.0001 per share | |
| Ian Chan | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Nov 2024 | 777,100 | 777,100 | - | - | Stock option (right to buy) | |
| Ian Chan | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Nov 2024 | 787,300 | 787,300 | - | - | Stock option (right to buy) | |
| Ian Chan | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Nov 2024 | 787,300 | 787,300 | - | - | Stock option (right to buy) | |
| Ian Chan | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Nov 2024 | 577,500 | 577,500 | - | - | Stock option (right to buy) | |
| Jin Wook Miles Suk | Director, Co-CEO & Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Nov 2024 | 613,500 | 613,500 | - | - | Stock option (right to buy) |